Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Tofacitinib | 0.3 | uM | 4 | G-CSF | 10.0 | 70 | ||||
RA2159 | IL-6 | 100 | ug/mL | 4 | G-CSF | 11.0 | 46 | ||||
RA2159 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 4 | G-CSF | 9.0 | 54 | |
RA2159 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 4 | G-CSF | 8.0 | 35 | |
RA2159 | Sigma A6730 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | G-CSF | 11.0 | 43 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | G-CSF | 11.0 | 67 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IL-6 | 100 | ug/mL | 4 | G-CSF | 9.5 | 68 | |
RA2159 | Ruxolitinib | 0.3 | uM | 4 | G-CSF | 9.0 | 53 | ||||
N2586 | IL-6 | 100 | ug/mL | 4 | G-CSF | 11.0 | 43 | ||||
N2586 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 4 | G-CSF | 12.5 | 58 | |
N2586 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 4 | G-CSF | 12.0 | 76 | |
N2586 | Sigma A6730 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | G-CSF | 12.5 | 46 | |
N2586 | JNK-IN-8 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | G-CSF | 12.5 | 70 | |
N2586 | JNK-IN-11 | 0.3 | uM | IL-6 | 100 | ug/mL | 4 | G-CSF | 9.0 | 57 | |
N2586 | Ruxolitinib | 0.3 | uM | 4 | G-CSF | 9.5 | 56 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | G-CSF | 310.5 | 34 | ||||
RA2159 | EO1428 | 1.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | G-CSF | 77.0 | 61 | |
RA2159 | PI103 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 4 | G-CSF | 233.0 | 52 | |
RA2159 | Sigma A6730 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | G-CSF | 402.5 | 72 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | G-CSF | 205.5 | 56 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | G-CSF | 351.0 | 55 | |
RA2159 | Lestaurtinib | 0.3 | uM | 4 | G-CSF | 11.0 | 59 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 4 | G-CSF | 584.0 | 47 | ||||
N2586 | EO1428 | 1.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | G-CSF | 195.5 | 64 | |
N2586 | PI103 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 4 | G-CSF | 96.0 | 47 |